Overview

A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide anidulafungin and voriconazole to healthy subjects to determine the drug concentration in the lung.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Anidulafungin
Echinocandins
Voriconazole